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Female BALB/c mice were infected with coxsackievirus B3 in the diestrus, proestrus, estrus, or metestrus phases of the ovarian cycle.
Cycle stage was determined by vaginal smear. All mice were killed 7 days after infection. Females infected in the diestrus and especially the
proestrus phases developed myocarditis. CD4+ T cells expressing interferon-gamma (IFNg) infiltrate the myocardium in these two phases,
whereas CD4+ T cells expressing IL-4 are more frequent during estrus. Cardiac virus titers were determined 15 h and 7 days after infection.
No differences in virus titer were seen at 7 days. These studies show that natural hormone variations can have substantial effects on viral
pathogenicity presumably due to hormone effects on the immune system.
D 2004 Elsevier Inc. All rights reserved.
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A spike in luteinizing hormone release causes ovulation
in mammals with a transient drop in plasma estrogen and a
rise in plasma progesterone levels (Hillier, 1994). The estrus
cycle in mice can be divided into estrus, metestrus, diestrus,
and proestrus phases. Although there is substantial inter-
mouse variation, the average estrus cycle is 4–5 days
(Jablonka-Shariff et al., 1999). Various studies have shown
that female sex-associated hormones (estrogen and proges-
terone) influence immune responses both systemically and
in the female reproductive tract (Beagley and Gockel, 2003;
Gockel et al., 2003). Hormonal effects are quite diverse and
modulate both innate and adaptive immunity. Estrogen has
both immunoenhancing and immunosuppressing effects as
it increases interferon-gamma (IFNg) secretion (Fox et al.,
1991; Karpuzoglu-Sahin et al., 2001) but suppresses0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: Sally.Huber@uvm.edu (S. Huber).monocyte chemotactic protein-1 (MCP-1) release (Pervin
et al., 1998) and TNFa (Ito et al., 2001, 2002). Other effects
of estrogen include (1) promotion of antibody responses
either through inhibition of B lymphocyte apoptosis
(Grimaldi et al., 2002) or increase in antibody secretion
(Kanda and Tamaki, 1999); (2) augmentation in calcineurin
signaling (Rider and Abdou, 2001); and (3) promotion of
dendritic cell differentiation and antigen presentation
(Paharkova-Vatchkova et al., 2004). In contrast, progester-
one is considered to be immunosuppressive and inhibits
both humoral and cellular immunity including natural killer
cell activity (Szekeres-Bartho, 2002; Tanriverdi et al.,
2003). The effects of sex hormones may be dose dependent.
Some studies find that low doses of estrogen promote Th1
(IFNg) cytokines but high doses of the hormone augment
Th2 (IL-10) cytokine responses using T cell clones
(Correale et al., 1998; Gilmore et al., 1997). Hormone
levels naturally fluctuate throughout the ovarian cycle. This
fluctuation also results in a natural rhythm to the immune
system. Evaluation of CD4+ Th1 and Th2 responses in
women during the luteal and follicular phases of their cycle
indicates that Th2 cell responses are increased during the004) 16–23
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2000). This raises the question whether the immune
response to virus varies depending upon the phase of the
ovarian cycle at the time of immunization. Ovarian cycle
stage or exogenous hormone treatments can alter suscept-
ibility to infection with organisms implicated in sexually
transmitted diseases including Neisseria gonorrhoeae (Kita
et al., 1991), herpes simplex virus-2 (Baker and Plotkin,
1978; Gallichan and Rosenthal, 1996), and human papil-
lomaviruses (Webster et al., 2001). The stage of the estrus
cycle also alters the effectiveness of vaccination with
immunization during the estrogen-dominant phases (estrus
and proestrus), enhancing antibody levels in the female
reproductive tract (Gockel et al., 2003).
Myocarditis is an inflammation of the heart muscle that
usually follows microbial infection (Gauntt and Huber,
2003). Among viruses, enteroviruses and adenoviruses are
the most frequent etiological agents (Bowles et al., 2002,
2003). Cardiac damage results from multiple pathogenic
mechanisms. Virus replication directly causes apoptosis of
myocytes and induces myocardial dysfunction through
cleavage of contractile proteins (Badorff et al., 1999,
2000; Henke et al., 2000). TNFa and IL-1h suppress
myocyte contractility (Freeman et al., 1998). Additionally,
both virus specific immunity and autoimmunity to myocytes
result in tissue destruction (Fairweather et al., 2001). Both
clinically and in at least some murine models, myocarditis is
more severe in males than females, except peri-partum when
disease in females may be quite severe (Huber et al., 1981;
Lyden and Huber, 1984; Woodruff, 1980). In the gender-
biased model of myocarditis, pathogenicity correlates to
induction of CD4+ Th1 (IFNg+) responses in males while
resistance correlates to a CD4+ Th2 (IL-4+) cell response
(Huber and Pfaeffle, 1994a; Huber et al., 1999). Similarly,
third-trimester pregnant females also show increased myo-
carditis susceptibility that correlates with biased Th1
responses (Lyden and Huber, 1984). Although virgin
females are generally myocarditis resistant, occasional
virgin females develop cardiac inflammation subsequent to
virus infection (Huber, personal observations). The obser-
vation that occasional virgin females are myocarditis
susceptible raises the question whether these females were
infected during a specific phase of their estrus cycle when
hormone levels favor coxsackievirus pathogenicity. This
study shows that female mice infected during the proestrus
phase develop significantly more myocarditis than animals
infected during estrus or metestrus phases.Fig. 1. Plasma hormone levels in different phases of the ovarian cycle.
BALB/cJ female mice were determined to be in specific cycle phases based
on vaginal smears and killed within 3 h to obtain plasma. Estradiol and
progesterone levels were determined by ELISA. Results represent mean F
SEM of 10 mice/group.Results
Hormone levels in plasma at different stages of the estrus
cycle
Female BALB/cJ mice (5 mice/phase) in diestrus (D),
proestrus (PE), estrus (E), or metestrus (M) phases of theestrus cycle were killed within 3 h of vaginal smear for
plasma isolation. Estradiol and progesterone levels were
determined by ELISA. Fig. 1 shows hormone levels in the
plasma and indicates high estradiol in proestrus and lower
levels in diestrus and metestrus phases. Progesterone
concentrations were similar in diestrus, proestrus, and
estrus, but were reduced in metestrus.
Infection of female mice at different stages of their estrus
cycle alters myocarditis susceptibility
Female BALB/cJ mice were infected with the H3 variant
of CVB3 at the diestrus, proestrus, estrus, or metestrus
phases of their cycle. All mice were killed 7 days after
infection. Fig. 2 shows representative histology of the hearts
and Fig. 3 shows average lesions per heart section. These
results demonstrate that females infected in the proestrus
phase develop substantially more myocarditis (average 13
lesions) than when infected in the estrus (average three
lesions) and metestrus (average two lesions). Lesion size
was similar and approximately 10–20 mononuclear cells/
lesion. Fig. 4 gives the cardiac virus titers of individual mice
and shows that while myocarditis severity differs, there is no
significant variation in virus in the heart.
Cytokine response in infected mice
Previously (Huber et al., 1999), we have shown that
myocarditis correlates with preferential Th1 (IFNg+)
responses during CVB3 infection. Frozen sections of
perfused hearts were labeled with antibodies to CD4 (blue),
IFNg (green), and IL-4 (red), and evaluated by confocal
microscopy (Fig. 5). CD4+ IFNg+ cells were significantly
increased in the myocardium of mice infected in the diestrus
and proestrus phases compared to mice in estrus and
metestrus. No CD4+ IFNg+ or CD4+ IL-4+ cells were
seen in the myocardium of uninfected females, demonstrat-
ing that infection is required for CD4+ T cell infiltration into
the heart. CD4+ IL-4+ cell numbers were increased in
Fig. 2. Representative histology of the myocardium of mice infected with CVB3 in the different ovarian cycle phases. Mice were killed 7 days after infection.
Hearts were formalin fixed, sectioned, and stained with hematoxylin and eosin. Arrows indicate inflammation.
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metestrus showed minimal numbers of either CD4+
IFNg+ or CD4+ IL-4+ cells by confocal. A potential
problem is that evaluations by confocal microscopy may
miss inflammatory cells since only a few sections are
evaluated per animal. A second method for inflammatory
cell evaluation in the heart involves enzymatic digestion of
the heart and recovery of mononuclear cell populations.
These cells are stimulated with PMA and ionomycin with
brefeldin A (BFA), and labeled for CD4, IFNg, and IL-4
(Fig. 6). Basically, greater numbers of CD4+ IFNg+ are
found in diestrus and proestrus while greater numbers of
CD4+ IL-4+ cells are found in estrus. In metestrus, both
CD4+ IFNg+ and CD4+ IL-4+ cells are found in roughlyFig. 3. Number of inflammatory lesions per section in the hearts of mice
infected at different phases of the ovarian cycle. Each dot represents an
individual animal. *Significantly more than estrus (PE) at P b 0.05.equivalent numbers. Total mononuclear cell recovery per
heart was 5.3 F 3.4  105 (diestrus; P b 0.05 compared to
estrus); 8.1 F 2.9  105 (proestrus; P b 0.05 compared to
estrus); 1.7 F 0.7  105 (estrus); and 0.6 F 0.4  105
(metestrus). Mononuclear cell isolation from uninfected
proestrus mice was b103 cells/heart. These results show that
there were both quantitative and qualitative differences inFig. 4. Cardiac virus titer in female mice infected in the different phases of
the ovarian cycle using the plaque forming assay. Hearts were obtained 1
and 7 days after infection of female mice in the different ovarian cycle
phases with 104 PFU CVB3. Hearts were perfused with PBS to remove
blood, homogenized, and tittered for virus. *Significantly different than
estrus at P b 0.05.
Fig. 5. Confocal microscopy of cytokine expression in the heart. Frozen sections of the heart were labeled for CD4 (blue), IFNg (green), and IL-4 (red) and
evaluated by confocal microscopy. Magnification, 40.
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times of the ovarian cycle.Discussion
Hormones have multiple effects, including (1) direct
effects in vitro on virus infection of cardiac myocytes and
endothelial cells (Lyden et al., 1987); (2) alterations in
chemokine expression and inflammatory cell chemotaxis
(Pervin et al., 1998); (3) modification of dendritic cell
differentiation and antigen presentation (Paharkova-Vatch-
kova et al., 2004); and (4) alterations in pro- or anti-
inflammatory cytokines (Correale et al., 1998; Fox et al.,
1991; Gilmore et al., 1997; Karpuzoglu-Sahin et al., 2001).
Any one or more of these hormone effects could impactFig. 6. Intracellular cytokine staining of inflammatory cells isolated from the hear
were individually minced and enzymatically digested to release inflammatory
ionomycin with brefeldin A for 4 h, then labeled with antibody to CD4, IFNg, and
diagrams are given for an individual proestrus and estrus mouse. The graph sum
mean F SEM. *Significantly different than estrus phase at P b 0.05.myocarditis susceptibility by altering infection, innate, or
adaptive immunity. This communication shows that the
timing of virus infection relative to the ovarian cycle in
females can have a substantial effect on viral pathogenesis.
Specifically, with coxsackievirus-infected mice, injection of
virus in the diestrus and proestrus phases results in
significantly more myocarditis that when females are
infected in estrus or metestrus. The change in pathogenicity
most likely does not reflect alteration in virus replication.
By 24 h after infection, virus titers in the heart are within
one log10 irrespective of ovarian cycle. Titers are slightly,
but significantly, elevated in mice infected during diestrus,
but titers in females infected in proestrus are slightly lower
than in the other phases. By 7 days after infection, titers in
proestrus and estrus mice are slightly higher than in animals
infected in diestrus and metestrus. Because the murinet. Hearts from at least five mice infected in each phase of the ovarian cycle
cells. The mononuclear lymphoid cells were stimulated with PMA and
IL-4 as indication of CD4+ Th1 (IFNg+) and CD4+ Th2 (IL-4+) cells. Flow
marizes the data for all mice in each group. Results in the graph represent
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day 7 might not reflect crucial initial alterations in the heart
immediately after infection, which ultimately determine
pathogenicity. A stronger correlation was observed between
CD4+ Th1 cells and pathogenicity. Approximately 4-fold
more mononuclear cells can be recovered from hearts of
females infected during proestrus compared to estrus. A
higher percentage of CD4+ T cells infiltrating the heart of
females infected in diestrus and proestrus are IFNg+ while
few express IL-4. In contrast, a high percentage of CD4+ T
cells are IL-4+ in the hearts of mice infected during the
estrus phases. Previous studies have shown that Th1
immunity to CVB3 promotes pathogenicity but Th2
immunity is protective in this model of myocarditis (Huber
and Pfaeffle, 1994a; Huber et al., 1999, 2002). The relative
roles of CD4+ Th1 and Th2 cells in myocarditis probably
vary between CVB3 myocarditis models. Studies by
Afanasyeva et al. (2001) indicate that a model of auto-
immune myocarditis may depend on Th2-biased immunity.
Even with the CVB3 variant used here, the type of
immunopathogenicity involved in myocarditis varies with
the genetics of the host. DBA/2 mice develop a humorally
mediated, Th2 cell-dependent disease while BALB/c mice
develop a Th1 cell-mediated disease (Huber, 1997; Huber
and Lodge, 1986).
It is not clear why the time of infection relative to the
ovarian cycle alters CD4+ Th cell responses. For example,
in both diestrus and metestrus, estrogen levels are reduced
compared to proestrus and estrus phases, but mice in
diestrus develop myocarditis while those in metestrus do
not. Thus, susceptibility cannot directly reflect estrogen
levels. Nor can absolute progesterone levels explain
susceptibility since this hormone is increased in diestrus,
proestrus, and estrus, but only mice in the first two phases
show enhanced susceptibility. A possible explanation is that
interactions between hormones, rather than absolute con-
centrations of a specific hormone, provide the conditions
necessary for myocarditis susceptibility. What those con-
ditions are is currently not known. Estrogen suppresses
TNFa responses (Ito et al., 2001, 2002), a cytokine known
to promote myocarditis susceptibility (Lane et al., 1992,
1993). Also, TNFa upregulates expression of decay
accelerating factor, a receptor for coxsackieviruses (Ahmad
et al., 2003; Bergelson et al., 1997; Selinka et al., 2002).
This suggests that high estrogen should suppress myocardi-
tis by limiting TNFa response to infection or by restricting
infectability of the heart due to reduced decay accelerating
factor expression. This might explain the increased suscept-
ibility in diestrus as there is a significant increase in cardiac
virus titer when estrogen is low. It does not explain the
increased susceptibility in proestrus. The greater suscepti-
bility in proestrus might simply reflect a delay in the loss of
this susceptibility once estrogen levels increase in proestrus.
If the hormones alter transcription of mRNA coding for
proteins conducive to myocarditis pathogenicity, the half-
life of the translated proteins may extend into the nextovarian phase. In such a case, the resistance in estrus would
reflect not only the high estrogen in the estrus phase but also
the increased estrogen in the preceding proestrus phase as
well.
These results are somewhat contradictory to our pre-
viously published observations (Huber and Pfaeffle, 1994b;
Huber et al., 1982, 1999; Lyden and Huber, 1984; Lyden et
al., 1987). These studies demonstrated that exogenous
treatment of female mice with progesterone strongly
enhanced both myocarditis and CD4+ Th1 immunity to
coxsackievirus infection, while exogenous estrogen was
protective. This contrasts to the observation in this
communication that maximal myocarditis occurs in females
infected during proestrus when both estradiol and proges-
terone levels are elevated. One would have hypothesized
that only females in diestrus should have shown increased
susceptibility based on our previously published studies.
There are difficulties with studies employing exogenous
hormone. First, ovarectomizing and hormone implanting
females (Huber et al., 1982) fail to evaluate the complex
interactions between the constantly fluctuating estradiol and
progesterone levels that occur during the normal ovarian
cycle. Secondly, implants provide a constant hormone level
over extended time periods, which is not physiologic.
Implants often fail to reproduce the hormone levels seen
in nonpregnant females. For example, estradiol implants
resulted in plasma estradiol levels exceeding 1000 pg/ml
(Huber et al., 1999). This is approximately 143 times higher
than the plasma levels observed in proestrus.
The biological significance is that it might explain at
least some of the clinical cases of myocarditis in women.
Approximately two-thirds of myocarditis occurs in men
(Wisten et al., 2002; Woodruff, 1980), making gender a
significant risk factor in this disease. Postpartum myocardi-
tis accounts for some of the cases in women, but cannot
explain all myocarditis occurring in this sex (Borczuk et al.,
1997; Woodruff, 1980). An important question, then, is why
some nonpregnant women are susceptible to myocarditis. It
seems reasonable from the data presented here that the
timing of enterovirus infections in women might influence
their susceptibility to developing clinical myocarditis,
provided the murine model is representative of at least
some clinical forms of this disease. Nonetheless, since Th1
and Th2 responses vary throughout the ovarian cycle, it is
reasonable that myocarditis dependent on Th2-biased
immunity may still depend upon the phase in which
infection occurs.
Relatively few studies have been done evaluating the
ovarian cycle and virus pathogenicity. Most notable are
studies on HIV/SHIV that showed modulation of co-
receptor expression during the menstrual cycle, variations
in viral RNA levels (virus concentrations), and mucosal
immunity (Greenblatt et al., 2000; Ochiel et al., 2003;
Yeaman et al., 2003). These studies, while not confirmed by
all investigators (Reichelderfer et al., 2002), indicate that
natural hormonal variations can impact viral diseases.
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papillomavirus have been observed during the menstrual
cycle in women (van Ham et al., 2002), although this may
reflect adequacy of sampling rather than effects on virus
shedding (McNicol et al., 1990). No differences were found
in natural killer or antibody-dependent cellular cytotoxicity
against herpes simplex virus-infected cells when using
effector cells from volunteers at different phases of the
menstrual cycle (Gonik et al., 1985). In contrast, low levels
of progesterone and estradiol in the luteal phase of the
ovarian cycle were found to increase antibody titers to
Candida albicans while high levels of estradiol in the late
follicular phase inhibited antibody titers (Mathur et al.,
1978). Thus, studies evaluating infectious diseases and the
ovarian cycle are relatively sparse. This communication
differs from those on retroviruses since hormone fluctua-
tions had inconclusive effects on virus titers.Materials and methods
Mice
BALB/cJ female mice were purchased from Jackson
Laboratories, Bar Harbor, ME, at 4 weeks of age. The mice
were rested for 1 week before vaginal smears were begun.
Virus infection and titration
The H3 variant of CVB3 was used (Knowlton et al.,
1996). Adult mice were infected by intraperitoneal injection
with 104 PFU virus in phosphate-buffered saline (PBS).
Animals were killed 7 days after infection. Hearts were
removed and tittered using the plaque forming assay
(Knowlton et al., 1996).
Vaginal smears
Vaginal epithelial cells were obtained from mice and
smeared onto precleaned Superfrost Plus slides. Smears
were done between 8 and 11 am each day. Slides were
stained with Hematoxylin, modified Papanicolaou stain
OG6, and Papanicolaou modified EA stain. Slides were
then cover slipped and evaluated for presence of white
blood cells and presence and morphology of epithelial cells
to determine estrus cycle stage as previously published
(Cohen et al., 2002). Smears were done for 1 week to
establish cycles in individual mice. During the second week
of evaluation, mice in specific cycle phases were infected
with virus.
Hormone determination
Estradiol (pg/ml) and progesterone (ng/ml) were deter-
mined from frozen EDTA plasma samples run in duplicate
using ELISA kits obtained from Cayman Chemical (AnnArbor, MI). Data were collected using a Biotek EL808
spectrophotometric plate reader (Biotek Instruments,
Winooski, VT) and analyzed using KC4 software (Biotek
Instruments).
Histology
The apical half of the heart was fixed in 10% buffered
formalin, sectioned, stained with hematoxylin and eosin,
and evaluated for myocarditis by image analysis as
described previously (Knowlton et al., 1996). Analysis
was performed in a double-blinded manner. Slides were
coded and the code was not broken until the analysis was
completed.
Flow cytometry
Details for intracellular cytokine staining have been
published previously (Huber et al., 2001). Briefly, hearts
were perfused with 10 ml PBS, removed, minced finely, and
digested with 0.4% collagenase type II (Cooper Biomedical,
Freehold NJ) and 0.25% pancreatin (Life Technologies).
Debris was allowed to settle, and the supernatant containing
the inflammatory cells were centrifuged on Histopaque
(Sigma, St. Louis MO). The cells at the interface were
washed and 106 cells were cultured for 4 h in RPMI 1640
medium containing 5% fetal bovine serum, 10 Ag of
Brefeldin A (BFA), 50 ng/ml phorbol myristate acetate
(PMA), and 500 ng/ml ionomycin (Sigma). After culture,
the cells were washed in PBS–1% bovine serum albumin
(BSA; Sigma) containing BFA, fixed in 2% paraformalde-
hyde for 10 min, then resuspended in PBS–BSA containing
0.5% saponin, Fc Block, and 1:100 dilutions of FITC anti-
IFNg and PE-anti-IL-4 (clones XMG 1.2 and BVD4-1D11)
or FITC- and PE-rat IgG1 (clone R3-34), and incubated for
30 min on ice. The cells were washed once in PBS–BSA–
saponin and once in PBS–BSA, then resuspended in 2%
paraformaldehyde, and analyzed using a Coulter Epics Elite
flow cytometer with a single excitation wavelength (488
nm) and band filters for FITC (525 nm) and PE (575 nm).
The cell population was classified for cell size (forward
scatter) and complexity (side scatter). At least 10000 cells
were evaluated. Positive staining was determined relative to
isotype controls.
Confocal microscopy
Hearts were perfused with PBS, snap frozen in Tissue
Freezing Medium (Triangle Biological Sciences, TBS,
Durham, NC) in liquid nitrogen, then sectioned using a
TBS cryostat into 10-Am sections and placed on glass slides
(Fisher Superfrost Plus, Fisher Scientific, Pittsburgh, PA).
Tissue was fixed for 10 min in 20 8C acetone, rehydrated
in phosphate-buffered saline containing 1% bovine serum
albumin (BSA) for 20 min, incubated for 30 min in PBS–
BSA containing 1% normal goat serum, then incubated for 1
J. Schwartz et al. / Virology 330 (2004) 16–2322h in PBS–BSA containing a mixture of 1:100 dilutions of
APC-Cy7 anti-CD4 (clone RM4-5; Pharmingen), Alexa 488
anti-IFNg (clone R4-6A2; Pharmingen), and PE anti-IL-4
(clone 11B11; Pharmingen). The tissues were washed three
times and evaluated using a BioRad MRC 1000 confocal
scanning laser system (Hercules, CA) mounted to an
Olympus BX 50 microscope using an iris setting of 2.0.
Magnification was 100. To evaluate numbers of cells, 10
microscopic fields were read per heart and averaged.
Average lymphocyte numbers from five or more mice are
reported.
Statistics
Statistical analysis was done by Wilcoxon Ranked Score.Acknowledgments
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